Gail K. Naughton Ph.D.

Gail K. Naughton Ph.D.

Founder and Scientific Advisor. at Histogen Inc.

Are you Gail K. Naughton Ph.D.? Claim your profile
 
  • IDENTIFY executive and board member connections in Gail K. Naughton Ph.D.'s network.
  • FOLLOW changes in Gail K. Naughton Ph.D.'s employment.
  • CONNECT with Gail K. Naughton Ph.D. through your network of contacts.

Gail K. Naughton Ph.D.'s Executive Work History


Current
Founder and Scientific Advisor.,
Founder and Scientific Advisor.
Equilar on 01/03/2023
Histogen Inc.
Board Member,
Board Member
TherapeuticsMD, Inc. 10-K/A on 04/29/2022
TherapeuticsMD, Inc.
Board Member,
Board Member
CEL-SCI Corporation 8-K on 08/08/2022
CEL-SCI Corporation
Board Member,
Board Member
Equilar on 10/04/2022
Centre for Commercialization of Regenerative Medicine
Board Member,
Board Member
Equilar on 09/14/2022
La Jolla Institute for Immunology
Past
To view Gail K. Naughton Ph.D.'s complete executive work history,
Education
B.S., Saint Francis College
B.S., St. Francis College
M.S., New York University - New York University School of Medicine
M.B.A., University of California, Los Angeles
Ph.D., New York University - New York University School of Medicine
Age
66
 

Gail K. Naughton Ph.D.'s Biography


Gail K. Naughton, Ph.D. serves as Histogen’s Founder and Scientific Advisor.  She previously served as our Chief Scientific Officer & Founder since the Merger in May 2020 to May 31, 2021. Dr. Naughton founded Private Histogen in 2007 and served as its Chief Scientific Officer, Chief Business Officer & Founder from 2007 until 2020. She has spent more than 30 years extensively researching the tissue engineering process, holds more than 100 U.S. and foreign patents and has been extensively published in the field. She previously served as co-founder and co-inventor of Advanced Tissue Sciences, a manufacturer of human skin for wound healing and skin treatments. At ATS, Dr. Naughton held a variety of key management positions, including president, chief operating officer, chief scientific officer and principal scientist. While serving as an officer and director of the company, Dr. Naughton oversaw the design and development of the world’s first up-scaled manufacturing facility for tissue engineered products, established corporate development and marketing partnerships with companies including Smith & Nephew, Ltd., Medtronic and Inamed Corporation, was pivotal in raising over $350M from the public market and corporate partnerships, and brought four human cell-based products from concept through FDA approval and market launch. Following ATS, Dr. Naughton served as Dean of the College of Business Administration at San Diego State University from 2002 until 2011, where she helped to make SDSU the first US campus to establish a Ph.D./MBA in life sciences. In 2000, Dr. Naughton received the 27th Annual National Inventor of the Year award by the Intellectual Property Owners Association in honor of her pioneering work in the field of tissue engineering. Dr. Naughton received her Ph.D. and M.S. from NYU Medical, and an MBA from UCLA. She currently sits on several scientific advisory boards.

Source: Histogen Inc. on 01/03/2023

 

By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Gail K. Naughton Ph.D.. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Gail K. Naughton Ph.D.'s network.
  • FOLLOW changes in Gail K. Naughton Ph.D.'s employment.
  • CONNECT with Gail K. Naughton Ph.D. through your network of contacts.
 

Access over 1,500,000 executive and board member profiles.

Example: Gail K. Naughton Ph.D.

Gail K. Naughton Ph.D.'s Connections (183)


Lynda Stuart M.D., Ph.D.
Former Board Member, La Jolla Institute for Immunology
Patricia B. Prichep
Senior VP, Operations, CEL-SCI Corporation
Daniel H. Zimmerman Ph.D.
Senior Vice President of Cellular Immunology, CEL-SCI Corporation
Christopher J. Calhoun
Former Chief Executive Officer, Plus Therapeutics, Inc.
Duncan Stewart
Board Member, Centre for Commercialization of Regenerative Medicine
Cynthia Lavoie Ph.D.
President and Chief Investment Officer, CCRM Enterprises Ltd., Centre for Commercialization of Regenerative Medicine
Gregory A. Bonfiglio
Board Member, ImmuneBridge Inc.
Vivek Goel
Board Member, Centre for Commercialization of Regenerative Medicine
David F. Melcher
Chairman, Embecta Corp.
Rochelle Fuhrmann
Board Member, Histogen Inc.